&nbsp;

Jul 2025

Drug

iBRUtinib

Other Name(s): Imbruvica®

Quick Link(s):

Aug 2025

Regimen

IBRUVENE

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - For the treatment of patients with chronic lymphocytic leukemia (CLL), in combination with venetoclax, based on criteria

Exceptional Access Program

venetoclax - For the treatment of patients with chronic lymphocytic leukemia (CLL), in combination with ibrutinib, based on criteria

Drugs Used:

iBRUtinib,

venetoclax

Quick Link(s):

Regimen Monograph

Aug 2025

Drug

fulvestrant

Other Name(s): Faslodex®

Quick Link(s):

Aug 2025

Regimen

FLVS

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

fulvestrant

Drugs Used:

fulvestrant

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IRINTMZL

Cancer Type:

Sarcoma,

Ewing's

Intent: Palliative

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

irinotecan,

temozolomide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IRIN+CETU; IRIN(Q2W)+CETU

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Cetuximab with Irinotecan - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

cetuximab,

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IRIN(Wx4); IRIN

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IRIN

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IRIN(Wx4)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2025

Drug

flutamide

Other Name(s): Euflex®

Quick Link(s):

Updated

Aug 2025

Drug

irinotecan

Other Name(s): Camptosar®

Quick Link(s):